Cargando…

Clinicopathological significance and a potential drugtarget of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic review

Lung cancer is the leading cause of cancer-related mortality in men worldwide. Aberrant RARβ promoter methylation has been frequently investigated in non-small-cell lung carcinoma (NSCLC), the most common form of lung cancer. The aim of present study was to carry out a meta-analysis and a systematic...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Xiaoyun, Shi, Kang, Zhou, Shi-Jie, Yu, Da-Ping, Liu, Zhidong, Han, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827914/
https://www.ncbi.nlm.nih.gov/pubmed/27103788
http://dx.doi.org/10.2147/DDDT.S96766

Ejemplares similares